Literature DB >> 7917104

Role of tyrosine kinases in lymphocyte activation.

B M Sefton1, J A Taddie.   

Abstract

Interaction of T- and B-cell antigen receptors with cytoplasmic non-receptor tyrosine protein kinases is critical to the activation of lymphocytes by antigen. Both the src-family tyrosine protein kinases Lck, Fyn, Lyn and Blk and the syk-family tyrosine protein kinases Syk and ZAP-70 play a role in lymphocyte activation. The antigen receptors are coupled to this cluster of kinases by the cytoplasmic tails of the gamma, delta, epsilon, zeta, and eta subunits of the T-cell receptor, and the Ig-alpha and Ig-beta subunits of the B-cell receptor. Each of these proteins contains one or more 'tyrosine based activation motifs', with the amino acid sequence D/EX7D/EXXYXXL/IX7YXXL/I. This motif appears to allow binding of one or more src-like kinases, via their unique amino termini, before the onset of lymphocyte activation. Invariant tyrosines in the motif become phosphorylated following the triggering of lymphocyte activation, and this modification induces the binding of the src- and syk-family tyrosine protein kinases, and potentially other signalling molecules, through SH2 domains to the antigen receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917104     DOI: 10.1016/0952-7915(94)90115-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  15 in total

Review 1.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

2.  The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation.

Authors:  G Texido; I H Su; I Mecklenbräuker; K Saijo; S N Malek; S Desiderio; K Rajewsky; A Tarakhovsky
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 3.  Src Family Protein Kinase Controls the Fate of B Cells in Autoimmune Diseases.

Authors:  Xianzheng Zhang; Dan Mei; Lingling Zhang; Wei Wei
Journal:  Inflammation       Date:  2020-10-10       Impact factor: 4.092

Review 4.  Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance.

Authors:  Eijiro Yamada; Ting-Wen A Lee; Jeffrey E Pessin; Claire C Bastie
Journal:  Future Med Chem       Date:  2010-12       Impact factor: 3.808

5.  Kinetics and extent of T cell activation as measured with the calcium signal.

Authors:  C Wülfing; J D Rabinowitz; C Beeson; M D Sjaastad; H M McConnell; M M Davis
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

6.  Age-related changes in lck-Vav signaling pathways in mouse CD4 T cells.

Authors:  Gonzalo G Garcia; Richard A Miller
Journal:  Cell Immunol       Date:  2009-06-06       Impact factor: 4.868

7.  Non-responsiveness of antigen-experienced CD4 T cells reflects more stringent co-stimulatory requirements.

Authors:  M E Hamel; E Noteboom; A M Kruisbeek
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

Review 8.  Role of phosphoinositide 3-kinase signaling in mast cells: new insights from knockout mouse studies.

Authors:  Taro Fukao; Yasuo Terauchi; Takashi Kadowaki; Shigeo Koyasu
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

9.  Defective expression of p56lck in an infant with severe combined immunodeficiency.

Authors:  F D Goldman; Z K Ballas; B C Schutte; J Kemp; C Hollenback; N Noraz; N Taylor
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

Review 10.  Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?

Authors:  Manu Vatish; Eijiro Yamada; Jeffrey E Pessin; Claire C Bastie
Journal:  Arch Physiol Biochem       Date:  2009-10       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.